Androsoni Roberto, Netto Alfonso Apostólico, Macedo Rafael Rocha, Fasolin Ricardo Pozzi, Boni Guilherme, Moreira Rodrigo Fileto Gavaldão
Hospital IFOR, São Bernardo do Campo, SP, Brazil.
Rev Bras Ortop. 2014 Jan 3;48(6):538-544. doi: 10.1016/j.rboe.2013.12.019. eCollection 2013 Nov-Dec.
This paper has the purpose to analyze prospectively the treatment results in patients with chronic plantar fasciitis resistant to conservative treatment who underwent extracorporeal shock wave therapy (ESWT).
We evaluated 30 patients (36 feet); 16 (53.3%) patients were male and 14 (47.7%) female with mean age of 48.7 y.o., varying from 33 to 78 y.o.; 16 (53.3%) present the problem on the left side, 14 (46.7%) on the right ones and 6 (20%) bilateral; the symptomatology varied from 6 to 60 months, with the average of 13.58 months. These patients were submitted to a weekly ESWT session for 4 consecutive weeks. We measured the plantar fascia thickness millimeters with ultrasound and we applied American Orthopaedic Foot and Ankle Society (AOFAS) scale for ankle and hindfoot, and Roles & Maudsley scales in pre ESWT, after one, three and six months after and decrease in the plantar fascia thickness by the ultrasound ( = 0.011) along the different moments studied.
We observed improvement of the evaluated criteria ( < 0.001) and plantar fascia thickness by ultrasound ( = 0.011) at different time points studied.
The ESWT can be considered an important tool in the primary or adjuvant treatment of the chronic plantar fasciitis when associated with conventional therapies. This methodology is safe, non-invasive and provides precocious rehabilitation and return to regular activities considering the results of the statistical analysis. This resource provides decrease in the thickness of the plantar fascia.
本文旨在前瞻性分析接受体外冲击波疗法(ESWT)治疗的慢性足底筋膜炎患者的保守治疗效果。
我们评估了30例患者(36只脚);16例(53.3%)为男性,14例(47.7%)为女性,平均年龄48.7岁,年龄范围为33至78岁;16例(53.3%)左侧出现问题,14例(46.7%)右侧出现问题,6例(20%)双侧出现问题;症状持续时间从6个月至60个月不等,平均为13.58个月。这些患者连续4周每周接受一次ESWT治疗。我们用超声测量足底筋膜厚度(毫米),并在ESWT治疗前、治疗后1个月、3个月和6个月应用美国矫形足踝协会(AOFAS)踝与后足评分量表以及罗尔斯和莫兹利量表,并通过超声测量不同研究时间点足底筋膜厚度的减少情况(P = 0.011)。
在不同研究时间点,我们观察到评估标准(P < 0.001)和超声测量的足底筋膜厚度(P = 0.011)均有改善。
当与传统疗法联合使用时,ESWT可被视为慢性足底筋膜炎主要或辅助治疗的重要工具。考虑到统计分析结果,这种方法安全、无创,能提供早期康复并使患者恢复正常活动。该方法可使足底筋膜厚度减小。